心脏药物使用在杜氏肌力发育不良症心肌病的行动中
Carol A Wittlieb-Weber1, Brian F Birnbaum2, Chesney D Castleberry3
1Perelman School of Medicine at the University of Pennsylvania, Children's Hospital of Philadelphia, 3401 Civic Center Boulevard, Philadelphia, PA, 19104, USA. wittliebc@chop.edu.
Pediatric cardiology
|June 20, 2025
概括
杜氏肌肉衰竭 (DMD) 中心脏药物的使用表明,许多中度至重度心脏功能障碍的患者不接受指导方针导向治疗. 这些治疗方法的优化是必要的,以改善结果.
科学领域:
- 心脏病学 心脏病学
- 神经肌肉疾病 神经肌肉疾病
- 药理学 药理学是指药理学的学科.
背景情况:
- 杜氏肌肉发育不良 (DMD) 经常涉及心脏并发症,导致死亡率增加.
- 建议在DMD相关心肌病时进行共识导向医学疗法 (CDMT).
- 了解DMD当前的心脏药物治疗实践对于优化患者护理至关重要.
研究的目的:
- 为了分析心脏药物使用和CDMT的坚持,在一个潜在的队列的男性患有DMD.
- 评估左心室 (LV) 缩功能障碍的患病率及其管理.
- 识别潜在的障碍,以实现心脏药物的目标剂量.
主要方法:
- 自2021年以来,在ACTION Dystrophinopathy注册表中注册的患者的前性分析.
- 在入学和随访时对心脏药物使用的评估.
- 定义CDMT是同时使用ACEi/ARB/ARNI,BB和MRA.
主要成果:
- 在265名DMD患者中,超过一半 (57.7%) 患有 LV 缩功能下降;25.3% 患有中度/严重功能障碍.
- 在中度/严重功能障碍患者中,73.1%在随访时接受了CDMT,类似于入学 (70.6%).
- 在单个药物类别的患者中,只有23-28%的患者达到目标CDMT剂量.
结论:
- 很大一部分患有中度/严重 LV 功能障碍的 DMD 患者没有最佳的 CDMT.
- 实现目标药物剂量的障碍仍然存在,需要进一步调查.
- 对最佳心脏药物治疗策略的更好理解对于DMD心脏死亡率至关重要.
相关概念视频
01:30Cardiomyopathy II: Dilated Cardiomyopathy
30
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
30
01:29Cardiomyopathy V: Interprofessional Care
41
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
41
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
65
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
65
01:14Myocarditis III: Medical Management
20
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
20
01:25Cardiomyopathy I: Introduction and Classification
72
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
72
01:26Heart Failure Drugs: Inotropic Agents
745
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
745